StockPriceToday

Inogen Inc (INGN)

INGN stock price

Inogen Inc (INGN) is a medical technology company developing portable oxygen concentrators and respiratory therapy solutions for patients with chronic respiratory conditions.

About Inogen Inc

Chronic respiratory diseases present significant challenges for patients who require continuous oxygen therapy but face limitations from traditional oxygen delivery systems that restrict mobility, independence, and quality of life while imposing substantial healthcare costs and logistical complexity. These patient needs create substantial opportunities for medical device companies that can develop portable, efficient oxygen therapy solutions that enable patient mobility and independence while maintaining therapeutic effectiveness and reducing total cost of care. The global oxygen therapy market continues expanding as patient populations grow and demand increases for portable respiratory solutions. INGN stock price performance reflects the company's success in developing innovative oxygen therapy technologies.

Inogen has developed innovative portable oxygen concentrator technology that enables patients to maintain active lifestyles while receiving necessary oxygen therapy through lightweight, efficient devices that provide reliable oxygen delivery without the limitations of traditional oxygen tanks or stationary systems. The company's technology platform utilizes advanced engineering and manufacturing capabilities to create portable oxygen concentrators that offer superior performance, battery life, and reliability compared to competitive alternatives. Their innovation approach emphasizes patient mobility, device reliability, and ease of use that can significantly improve patient quality of life while reducing healthcare costs and improving treatment compliance.

Inogen's market performance and product adoption demonstrate strong execution capabilities in medical device development and commercialization while building strategic partnerships and expanding global market presence. The company's performance in product development, regulatory approvals, and market penetration reflects proven capabilities in addressing patient needs while creating sustainable competitive advantages in respiratory therapy markets. Future outlook depends on continued technology advancement, market expansion, and strategic development of innovative respiratory solutions that can capture growing demand for portable oxygen therapy while maintaining market leadership through superior product performance and customer satisfaction.

INGN Stock 12 Month Chart


Latest News for INGN

Noted a shift of large customer orders from Q4 2025 into the first half of 2026 due to customer capital and budgeting constraints. Transitioned to a new revenue reporting structure (U.S. Sales, ...

INGN posts narrower Q4 loss and 2% revenue rise, but shares dip as U.S. sales and rentals weaken despite international strength.

Q4 2025 earnings call recap: revenue growth, 2026 guidance, Simeox & CPAP expansion, margins, and $30M buyback—read key takeaways.